background
initi
report
may
novel
influenza
strain
estim
case
fatal
rate
cfr
similar
season
influenza
juli
howev
argentina
report
case
death
repres
cfr
potenti
explan
increas
cfr
includ
viru
reassort
genet
drift
infect
vulner
popul
viru
genom
sequenc
argentinian
sampl
repres
sever
mild
diseas
indic
evid
reassort
mutat
associ
resist
antivir
drug
genet
drift
might
contribut
virul
furthermor
evid
found
increas
frequenc
risk
factor
diseas
methodsprincip
find
examin
nasopharyng
swab
sampl
np
case
infect
argentina
masstag
pcr
test
addit
microbi
agent
studi
popul
consist
subject
sampl
june
juli
thirtynin
sever
diseas
defin
death
n
hospit
n
mild
diseas
least
one
addit
agent
potenti
pathogen
import
identifi
sampl
includ
streptococcu
pneumonia
n
haemophilu
influenza
n
human
respiratori
syncyti
viru
n
b
n
human
rhinoviru
n
b
n
human
coronavirus
n
n
klebsiella
pneumonia
n
acinetobact
baumannii
n
serratia
marcescen
n
staphylococcu
aureu
n
methicillinresist
aureu
mrsa
n
presenc
pneumonia
strongli
correl
sever
diseas
pneumonia
present
sever
case
versu
mild
case
onethird
np
pneumonia
subject
sever
diseas
pneumoniaeposit
np
p
subject
year
age
adjust
odd
ratio
sever
diseas
presenc
pneumonia
confid
interv
ci
conclusionssignific
associ
pneumonia
morbid
mortal
establish
current
previou
influenza
pandem
howev
studi
first
demonstr
prognost
signific
noninvas
antemortem
diagnosi
pneumonia
infect
may
provid
insight
clinic
manag
citat
palacio
g
hornig
cisterna
savji
n
bussetti
av
et
al
streptococcu
pneumonia
coinfect
correl
sever
pandem
influenza
plo
one
june
world
health
organ
declar
pandem
outbreak
respiratori
ill
associ
novel
influenza
viru
infect
consid
mild
howev
strain
seem
highli
transmiss
base
studi
commun
la
gloria
mexico
viru
first
detect
earli
worldwid
surveil
data
mathemat
model
cfr
estim
first
case
argentina
report
may
juli
two
month
later
number
case
argentina
total
death
repres
comput
cfr
although
could
exclud
possibl
elev
cfr
reflect
underreport
milder
infect
altern
bona
fide
increas
due
differ
level
host
pathogen
might
global
implic
risk
factor
commonli
associ
develop
sever
diseas
includ
advanc
age
chronic
ill
diabet
asthma
obes
immunosuppress
immunemedi
diseas
immunomodulatori
therapi
pregnanc
present
increas
frequenc
argentina
anoth
potenti
explan
higher
cfr
chang
viru
includ
reassort
virul
strain
develop
resist
antivir
therapi
genet
drift
result
virul
phenotyp
complet
genom
sequenc
sampl
repres
sever
mild
case
diseas
argentina
reveal
evid
consist
develop
virul
phenotyp
data
shown
third
factor
consid
bacteri
viral
coinfect
although
diseas
sever
previou
pandem
attribut
bacteri
superinfect
earli
report
among
individu
develop
countri
fail
correl
sever
diseas
coinfect
evalu
contribut
coinfect
mortal
observ
argentina
examin
case
previouslydiagnos
infect
argentina
includ
case
classifi
sever
case
categor
mild
use
masstag
pcr
multiplex
pcr
system
assess
microbi
agent
singl
reaction
np
specimen
patient
collect
june
juli
cours
outbreak
investig
pandem
influenza
argentina
analyz
masstag
pcr
presenc
potenti
sourc
coinfect
includ
viral
bacteri
respiratori
pathogen
prior
initi
masstag
pcr
studi
presenc
confirm
sampl
whoapprov
real
time
pcr
assay
subject
includ
patient
classifi
sever
diseas
base
hospit
n
death
n
patient
mild
diseas
present
ambulatori
clinic
five
patient
medic
condit
associ
increas
risk
sever
diseas
follow
influenza
infect
asthma
malnutrit
pregnanc
obes
immunosuppress
n
four
patient
sever
diseas
mild
diseas
p
examin
whether
age
group
typic
associ
greater
risk
influenzarel
complic
ie
young
children
elderli
also
higher
risk
sever
diseas
context
compar
sever
diseas
subject
year
age
year
age
high
risk
age
group
found
subject
year
age
low
risk
age
group
age
data
avail
subject
although
mean
age
sever
mild
diseas
subject
similar
sever
diseas
occur
high
risk
age
group
subject
compar
low
risk
age
group
subject
fisher
exact
test
tabl
howev
patient
sever
diseas
age
data
avail
low
risk
age
group
fisher
exact
test
trend
toward
higher
preval
sever
diseas
male
compar
femal
p
data
concern
antivir
antibiot
therapi
avail
subject
risk
sever
diseas
diminish
subject
receiv
oseltamivir
subject
receiv
oseltamavir
alon
sever
diseas
contrast
patient
receiv
antibiot
without
antivir
medic
sever
diseas
masstag
pcr
detect
least
one
addit
potenti
respiratori
pathogen
sampl
coinfect
agent
includ
pneumonia
n
h
influenza
n
human
respiratori
syncyti
viru
rsv
n
b
n
human
rhinoviru
hrv
n
b
n
human
coronaviru
hcov
n
n
k
pneumonia
n
baumannii
n
marcescen
n
aureu
n
mrsa
n
tabl
case
influenza
viru
found
presenc
pneumonia
associ
sever
diseas
pneumonia
detect
sever
case
mild
case
onethird
np
pneumonia
subject
sever
diseas
pneumoniaeposit
np
p
tabl
h
influenza
infect
frequent
studi
popul
case
harbor
agent
increas
among
subject
sever
diseas
wherea
mild
case
posit
bacterium
h
influenza
detect
sever
case
bacteri
agent
detect
case
includ
aureu
n
mrsa
n
k
pneumonia
n
marcescen
n
baumannii
n
subject
one
bacteri
respiratori
pathogen
pneumonia
h
influenza
np
sampl
mild
diseas
p
presenc
rsv
though
rel
infrequ
common
sever
case
mild
diseas
case
p
virus
includ
rsv
b
hrv
hcov
also
infrequ
case
case
hrv
b
sever
diseas
signific
relationship
pneumonia
sever
diseas
restrict
patient
low
risk
age
group
tabl
close
examin
influenc
presenc
pneumonia
np
sampl
sever
function
ageassoci
risk
pursu
multivari
logist
regress
analysi
stratifi
age
risk
group
model
adjust
presenc
np
rsv
total
number
agent
detect
np
presenc
medic
risk
factor
implic
sever
outcom
deriv
ensur
relationship
among
includ
variabl
low
nonsignific
conting
coeffici
rang
secondari
bacteri
infect
implic
morbid
mortal
influenza
analysi
lung
tissu
section
fatal
influenza
case
materi
frequent
reveal
histopatholog
find
consist
acut
bacteri
pneumonia
agent
recov
postmortem
cultur
lung
sampl
fatal
influenza
pandem
case
includ
pneumonia
haemolyticu
aureu
h
influenza
studi
argentinean
victim
presenc
pneumonia
np
predict
sever
diseas
outcom
risk
associ
pneumonia
particularli
promin
yearold
individu
inde
sever
diseas
low
risk
group
predict
accuraci
via
multivari
logist
regress
model
consid
presenc
pneumonia
togeth
virus
influenza
riskassoci
medic
condit
first
wave
pediatr
admiss
birmingham
uk
low
rate
bacteri
infect
found
children
case
seri
first
patient
hospit
mexico
citi
report
evid
coinfect
common
respiratori
virus
contrast
initi
report
base
clinic
data
wherein
coinfect
infrequ
recent
postmortem
analys
indic
lower
respiratori
tract
infect
lethal
case
unit
state
pneumonia
implic
case
synergist
pathogenesi
describ
influenza
viru
pneumonia
madhi
colleagu
demonstr
vaccin
pneumonia
reduc
frequenc
pneumonia
associ
influenza
rsv
parainfluenza
virus
anim
model
influenza
neuraminidas
shown
strip
sialic
acid
residu
expos
pneumococc
receptor
respiratori
epithelium
inde
potenc
neuraminidas
correl
capac
influenza
viru
strain
promot
pneumonia
three
practic
implic
emerg
studi
first
pneumonia
import
pathogenesi
prognosi
diseas
whether
effect
associ
pneumonia
sui
generi
specif
serotyp
remain
determin
second
easili
access
sampl
np
may
use
index
risk
sever
diseas
third
multiplex
diagnost
method
like
masstag
pcr
enabl
rapid
detect
broad
spectrum
viral
bacteri
agent
inform
clinic
care
routin
infecti
diseas
outbreak
specimen
collect
individu
hospit
pointofcar
institut
argentina
submit
administracion
nacion
de
laboratorio
e
instituto
de
salud
anli
clinic
inform
sampl
submit
anli
assign
new
uniqu
identifi
deidentifi
clinic
data
biolog
sampl
absenc
personallyidentifi
inform
assur
sampl
submit
deidentifi
code
instituto
nacion
de
enfermedad
infecciosa
inei
test
sampl
studi
randomli
select
anli
review
deidentifi
clinic
inform
provid
anli
hospit
pointofcar
institut
basi
review
chart
institut
inei
columbia
univers
cu
provid
follow
deidentifi
data
patient
age
sex
presenc
prior
medic
condit
known
associ
greater
morbid
mortal
influenza
infect
eg
diabet
chronic
pulmonari
diseas
cardiovascular
diseas
obes
immunosuppress
pregnanc
use
antimicrobi
drug
date
sampl
acquisit
geograph
region
patient
resid
inform
potenti
factor
associ
risk
sever
diseas
includ
presenc
passiv
tobacco
smoke
exposur
older
sibl
person
andor
famili
atop
background
unavail
inei
cu
maintain
approv
institut
review
board
irb
protocol
receipt
analysi
deidentifi
sampl
associ
deidentifi
clinic
data
sampl
studi
np
specimen
collect
anli
bueno
air
argentina
sampl
randomli
select
analysi
two
type
repositori
specimen
maintain
anli
collect
cours
standard
surveil
procedur
hospit
clinic
argentina
period
np
sampl
mild
case
n
np
sampl
sever
case
n
mild
case
defin
ambulatori
case
confirm
infect
sever
diseas
defin
basi
either
death
n
sever
pneumonia
requir
hospit
mechan
assist
n
prior
select
sampl
analysi
deidentifi
clinic
inform
hospit
clinic
use
approv
anli
personnel
classifi
case
mild
sever
specimen
submit
inei
archiv
follow
test
whoapprov
real
time
pcr
test
period
epidemiolog
week
rsv
infect
virusposit
case
report
argentinian
nation
respiratori
diseas
surveil
system
determin
whether
pattern
coinfect
respiratori
pathogen
among
patient
sever
diseas
differ
coinfect
pattern
observ
mild
diseas
np
specimen
select
randomli
total
sever
case
studi
along
np
select
randomli
among
ambulatori
mild
case
group
sampl
collect
total
rna
np
obtain
acid
guanidinium
thiocyanatephenolchloroform
extract
trireag
molecular
research
center
sampl
prepar
analyz
masstag
pcr
group
comparison
conduct
use
nonparametr
test
mannwhitney
u
test
continu
data
deviat
normal
distribut
fisher
exact
test
nomin
data
twotail
test
signific
pursu
analys
examin
diseas
sever
function
pneumonia
coinfect
creat
multivari
logist
regress
model
stratifi
age
risk
categori
high
risk
age
year
low
risk
age
year
outcom
interest
diseas
sever
sever
diseas
hospit
fatal
case
mild
diseas
nonhospit
nonfat
commun
case
model
adjust
rsv
coinfect
total
number
bacteri
viral
agent
detect
np
presenc
medic
risk
factor
variabl
check
correl
diseas
sever
depend
variabl
deriv
conting
coeffici
goodnessoffit
test
use
determin
fit
logist
regress
model
data
statview
window
version
sa
institut
spss
window
version
spss
inc
statist
softwar
employ
analys
test
level
signific
